Cannabis Use Disorder in Adolescence

Child and Adolescent Psychiatric Clinics of North America

Volumn 25, Issue 3, 2016, Pages 431-443

  Simpson, Annabelle K ^a   Magid, Viktoriya ^b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abuse; Adolescent; Cannabis; Cannabis use disorder; Dependence; Marijuana; Teenager

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACETYLCYSTEINE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABIS; DRONABINOL; GABAPENTIN; NABILONE; NABIXIMOLS; PLACEBO;

ABDOMINAL DISCOMFORT; ADOLESCENT BEHAVIOR; AGE; BEHAVIOR THERAPY; CANNABIS ADDICTION; CLINICAL FEATURE; COGNITIVE THERAPY; COORDINATION DISORDER; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG WITHDRAWAL; DSM-5; FAMILY THERAPY; HEADACHE; HEARTBURN; HIGH RISK POPULATION; HUMAN; INSOMNIA; INTOXICATION; MEMORY DISORDER; MYALGIA; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NONHUMAN; NOSE OBSTRUCTION; PARANOIA; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; REVIEW; SIDE EFFECT; SPASTICITY; THERAPY EFFECT; VIVID DREAM; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; ADOLESCENT; MARIJUANA ABUSE;

ADOLESCENT; CANNABIS; HUMANS; MARIJUANA ABUSE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84975503935     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2016.03.003     Document Type: Review

References (26)

1. Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH series H-50). 2015. Available at:. Accessed November 20, 2015. http://www.samhsa.gov/data/.
2. Center for Behavioral Health Statistics and Quality The Center for Behavioral Health Statistics and Quality report: profile of adolescent discharges from substance abuse treatment 2015, Substance Abuse and Mental Health Services Administration, Rockville (MD).
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-5. Cannabis-related disorders 2013, 509-519. American Psychiatric Association, Washington, DC.
4. Budney A.J., Roffman R., Stephens R.S., et al. Marijuana dependence and its treatment. Addict Sci Clin Pract 2007, 4(1):4-16.
5. Substance Abuse and Mental Health Services Administration Behavioral health barometer: United States, 2014. HHS Publication No. SMA-15-4895 2015, Substance Abuse and Mental Health Services Administration, Rockville (MD).
6. Meier M.H., Caspi A., Ambler A., et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 2012, 109(40):E2657-E2664.
7. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 2008, 1(1):81-98.
8. Molina K.M., Alegría M., Chen C.N. Neighborhood context and substance use disorders: a comparative analysis of racial and ethnic groups in the United States. Drug Alcohol Depend 2012, 125(Suppl 1):S35-S43.
9. Volkow N.D., Baler R.D., Compton W.M., et al. Adverse health effects of marijuana use. N Engl J Med 2014, 370(23):2219-2227.
10. Johnston L.D., O'Malley P.M., Miech R.A., et al. Monitoring the future National Survey Results on Drug Use: 1975-2014: overview, key findings on adolescent drug use 2015, Institute for Social Research, The University of Michigan, Ann Arbor (MI).
11. Greene M.C., Kelly J.F. The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation. J Addict Med 2014, 8(5):359-367.
12. Kroutil LA, Lipari R, Pemberton R. Risk and protective factors and initiation of substance use: results from the 2014 National Survey on Drug Use and Health. National Survey on Drug Use and Health Data Review. 2015. Available at:. Accessed November 20, 2015. http://www.samhsa.gov/data/.
13. Magid V., Settles R. Clinical guidelines for the detection, prevention and early intervention of adolescent substance use. Adolesc Psychiatry 2013, 3(2):200-207.
14. Marshall K., Gowing L., Ali R., et al. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 2014, (12). CD008940.
15. Center for Behavioral Health Statistics and Quality The Center for Behavioral Health Statistics and Quality report: a day in the life of young adults: substance use facts 2014, Substance Abuse and Mental Health Services Administration, Rockville (MD).
16. Center for Behavioral Health Statistics and Quality The treatment episode data set report: marijuana admissions to substance abuse treatment aged 18 to 30: early vs. adult initiation 2015, Substance Abuse and Mental Health Services Administration, Rockville (MD).
17. Copello P, Elizabeth A, Han B, et al. Receipt of services for behavioral health problems: results from the 2014 National Survey on Drug Use and Health. National Survey on Drug Use and Health Data Review. 2015. Available at:. Accessed November 20, 2015. http://www.samhsa.gov/data/.
18. Dennis M., Godley S.H., Diamond G., et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat 2004, 27(3):197-213.
19. Kamon J., Budney A., Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry 2005, 44(6):513-521.
20. Gray K.M., Carpenter M.J., Baker M.L., et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry 2012, 169(8):805-812.
21. Gray K.M., Watson N.L., Carpenter M.J., et al. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict 2010, 19(2):187-189.
22. Gray K.M. New developments in understanding and treating adolescent marijuana dependence. Adolesc Psychiatry (Hilversum) 2013, 3(4):297-306.
23. Mason B.J., Crean R., Goodell V., et al. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 2012, 37(7):1689-1698.
24. Weinstein A.M., Gorelick D.A. Pharmacological treatment of cannabis dependence. Curr Pharm Des 2011, 17(14):1351-1358.
25. Vandrey R., Stitzer M.L., Mintzer M.Z., et al. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend 2013, 128(1-2):64-70.
26. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow... and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012, 8(1):15-32.